Infliximab-graded challenge in a patient with Crohn’s disease and adalimumab hypersensitivity

被引：0
|
作者：
Christine H Song
Jaclyn A Quirt
Jason K Lee
机构：
[1] University of Toronto,Division of Allergy and Clinical Immunology, St. Michael’s Hospital
[2] McMaster University,Department of Internal Medicine
来源：
Allergy, Asthma & Clinical Immunology | / 8卷 / Suppl 1期
关键词：
Infliximab; Adverse Reaction; Adalimumab; Urticaria; Alternate Agent;
D O I：
10.1186/1710-1492-8-S1-A21
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn's disease
    Steenholdt, Casper
    Svenson, Morten
    Bendtzen, Klaus
    Thomsen, Ole Ostergaard
    Brynskov, Jorn
    Ainsworth, Mark Andrew
    JOURNAL OF CROHNS & COLITIS, 2012, 6 (01) : 108 - 111
  • [2] Flexural psoriasis induced by infliximab and adalimumab in a patient with Crohn's disease
    Avila Alvarez, A.
    Garcia-Alonso, L.
    Solar Boga, A.
    Garcia-Silva, J.
    ANALES DE PEDIATRIA, 2009, 70 (03): : 278 - 281
  • [3] Psoriasiform Skin Lesions Are Caused by Both Infliximab and Adalimumab in a Patient with Crohn’s Disease
    Eren Cankurtaran
    Fuat Ekiz
    Mevlut Hamamci
    Hakan Akinci
    Yusuf Coskun
    Ilhami Yuksel
    Digestive Diseases and Sciences, 2016, 61 : 1206 - 1207
  • [4] Effectiveness of infliximab after adalimumab failure in Crohn's disease
    María Chaparro
    Montserrat Andreu
    Manuel Barreiro-de Acosta
    Esther García-Planella
    Elena Ricart
    Eugeni Domènech
    María Esteve
    Olga Merino
    Pilar Nos
    Mireia Pealva
    Javier P Gisbert
    World Journal of Gastroenterology, 2012, (37) : 5219 - 5224
  • [5] Effectiveness of infliximab after adalimumab failure in Crohn's disease
    Chaparro, Maria
    Andreu, Montserrat
    Barreiro-de Acosta, Manuel
    Garcia-Planella, Esther
    Ricart, Elena
    Domenech, Eugeni
    Esteve, Maria
    Merino, Olga
    Nos, Pilar
    Penalva, Mireia
    Gisbert, Javier P.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (37) : 5219 - 5224
  • [6] Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohn’s Disease with no Relapse After Switching to Adalimumab
    Marilia Cravo
    Rosa Silva
    Miguel Serrano
    BioDrugs, 2010, 24 : 25 - 27
  • [7] Benefit of Infliximab Reintroduction after Successive Failure of Infliximab and Adalimumab in Crohn's Disease
    Gagniere, C.
    Beaugerie, L.
    Pariente, B.
    Seksik, P.
    Amiot, A.
    Abitbol, V.
    Allez, M.
    Cosnes, J.
    Sokol, H.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (04) : 349 - 355
  • [8] Elective Switching from Infliximab to Adalimumab in Stable Crohn's Disease
    Hoentjen, Frank
    Haarhuis, Bertram J. T.
    Drenth, Joost P. H.
    de Jong, Dirk J.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (04) : 761 - 766
  • [9] Response to Infliximab After Loss of Response to Adalimumab in Crohn's Disease
    Bauer, Christina M.
    Younis, Adam
    Herfarth, Hans
    Barnes, Edward L.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (02) : E5 - E5
  • [10] Effects of Infliximab Retreatment After Consecutive Discontinuation of Infliximab and Adalimumab in Refractory Crohn's Disease
    Brandse, Johannan F.
    Peters, Charlotte P.
    Gecse, Krisztina B.
    Eshuis, Emma J.
    Jansen, Jeroen M.
    Tuynman, Hans A.
    Loewenberg, Mark
    Ponsioen, Cyriel Y.
    van den Brink, Gijs R.
    D'Haens, Geert R.
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (02) : 251 - 258
12345